ADvantage Therapeutics Inc.
PrivateLast Round
Grant
Sep 26, 2025
Total Funding Raised
$23M
Company Overview
ADvantage Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Grant round in September 2025.
ADvantage Therapeutics Inc. is a biotechnology company that develops novel therapies for neurodegenerative conditions, with a primary focus on Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ADvantage Therapeutics Inc. Comparables
Compare ADvantage Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Klothea Bio, Inc. | 87% | |
| Klotho Therapeutics, Inc. | 85% | |
| Klotho Sciences | 84% |
For institutional investors. Book with your work email.
ADvantage Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 26, 2025 | ||||
| Seed | Nov 25, 2024 | ||||
| Early Funding | Jul 12, 2023 | ||||
| Seed | Jun 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ADvantage Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Seed |
| National Institute on Aging | Grant |
| quadraScope Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 45% MoM.
- Oct 9, 2025
Preparing for Phase 1B trial of next-generation Klotho therapeutics.
For institutional investors. Book with your work email.
ADvantage Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ADvantage Therapeutics Inc.'s valuation, stock price, and market status.
Is ADvantage Therapeutics Inc. a public or private company?
ADvantage Therapeutics Inc. is a private company.
What is the current stock price of ADvantage Therapeutics Inc.?
ADvantage Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks ADvantage Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ADvantage Therapeutics Inc. worth (valuation)?
Valuation information for ADvantage Therapeutics Inc. is not publicly available.
Can I buy ADvantage Therapeutics Inc. stock?
ADvantage Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ADvantage Therapeutics Inc.'s last funding round?
ADvantage Therapeutics Inc.'s most recent funding round was Grant on September 26, 2025.
Who are the main investors in ADvantage Therapeutics Inc.?
Key investors in ADvantage Therapeutics Inc. include Longevitytech.fund, National Institute on Aging.
Will ADvantage Therapeutics Inc. IPO soon?
No public IPO plans have been announced for ADvantage Therapeutics Inc..
How can I track ADvantage Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ADvantage Therapeutics Inc.'s shares on secondary markets.